Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1996 May;164(5):446–448.

Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.

S M Kallal 1, M Lee 1
PMCID: PMC1303550  PMID: 8686308

Full text

PDF
446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed F., Sumalnop V., Spain D. M., Tobin M. S. Thrombohemolytic thrombocytopenic purpura during penicillamine therapy. Arch Intern Med. 1978 Aug;138(8):1292–1293. [PubMed] [Google Scholar]
  2. Aymard J. P., Aymard B., Netter P., Bannwarth B., Trechot P., Streiff F. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):430–448. doi: 10.1007/BF03259895. [DOI] [PubMed] [Google Scholar]
  3. Bell W. R., Braine H. G., Ness P. M., Kickler T. S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991 Aug 8;325(6):398–403. doi: 10.1056/NEJM199108083250605. [DOI] [PubMed] [Google Scholar]
  4. Ellingson T. L., Wilske K., Aboulafia D. M. Case report: thrombotic thrombocytopenic purpura in a patient with polymyositis: therapeutic importance of early recognition and discussion of pathogenic mechanisms. Am J Med Sci. 1992 Jun;303(6):407–410. doi: 10.1097/00000441-199206000-00012. [DOI] [PubMed] [Google Scholar]
  5. Fahal I. H., Williams P. S., Clark R. E., Bell G. M. Thrombotic thrombocytopenic purpura due to rifampicin. BMJ. 1992 Apr 4;304(6831):882–882. doi: 10.1136/bmj.304.6831.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harkness D. R., Byrnes J. J., Lian E. C., Williams W. D., Hensley G. T. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA. 1981 Oct 23;246(17):1931–1933. [PubMed] [Google Scholar]
  7. Kwaan H. C. Miscellaneous secondary thrombotic microangiopathy. Semin Hematol. 1987 Jul;24(3):141–147. [PubMed] [Google Scholar]
  8. List A. F., Beaird D. H., Kummet T. Ranitidine-induced granulocytopenia: recurrence with cimetidine administration. Ann Intern Med. 1988 Apr;108(4):566–567. doi: 10.7326/0003-4819-108-4-566. [DOI] [PubMed] [Google Scholar]
  9. Mars D. R., Knochel J. P., Cotton J. R., Fuller T. J. Thrombotic thrombocytopenic purpura after a dogbite. South Med J. 1980 May;73(5):676–678. doi: 10.1097/00007611-198005000-00039. [DOI] [PubMed] [Google Scholar]
  10. Nalbandian R. M., Henry R. L. A proposed comprehensive pathophysiology of thrombotic thrombocytopenic purpura with implicit novel tests and therapies. Semin Thromb Hemost. 1980;6(4):356–390. doi: 10.1055/s-2007-1005109. [DOI] [PubMed] [Google Scholar]
  11. Noda M., Kitagawa M., Tomoda F., Iida H. Thrombotic thrombocytopenic purpura as a complicating factor in a case of polymyositis and Sjögren's syndrome. Am J Clin Pathol. 1990 Aug;94(2):217–221. doi: 10.1093/ajcp/94.2.217. [DOI] [PubMed] [Google Scholar]
  12. Page Y., Tardy B., Zeni F., Comtet C., Terrana R., Bertrand J. C. Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet. 1991 Mar 30;337(8744):774–776. doi: 10.1016/0140-6736(91)91383-6. [DOI] [PubMed] [Google Scholar]
  13. Parker J. C., Barrett D. A., 2nd Microangiopathic hemolysis and thrombocytopenia related to penicillin drugs. Arch Intern Med. 1971 Mar;127(3):474–477. [PubMed] [Google Scholar]
  14. Perotti C., Torretta L., Costamagna L., Salvaneschi L. Thrombotic thrombocytopenic purpura after defibrotide therapy. Haematologica. 1994 Nov-Dec;79(6):569–569. [PubMed] [Google Scholar]
  15. Petitt R. M. Thrombotic thrombocytopenic purpura: a thirty year review. Semin Thromb Hemost. 1980;6(4):350–355. doi: 10.1055/s-2007-1005108. [DOI] [PubMed] [Google Scholar]
  16. Ridolfi R. L., Bell W. R. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 1981 Nov;60(6):413–428. [PubMed] [Google Scholar]
  17. Ruggenenti P., Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am. 1990 Feb;4(1):219–241. [PubMed] [Google Scholar]
  18. Schmidt J. L. Thrombotic thrombocytopenic purpura: successful treatment unlocks etiologic secrets. Mayo Clin Proc. 1989 Aug;64(8):956–961. doi: 10.1016/s0025-6196(12)61223-3. [DOI] [PubMed] [Google Scholar]
  19. Shumak K. H., Rock G. A., Nair R. C. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group. Ann Intern Med. 1995 Apr 15;122(8):569–572. doi: 10.7326/0003-4819-122-8-199504150-00002. [DOI] [PubMed] [Google Scholar]
  20. Stonesifer L. D., Bone R. C., Hiller F. C. Thrombotic thrombocytopenic purpura in carbon monoxide poisoning. Report of a case. Arch Intern Med. 1980 Jan;140(1):104–105. [PubMed] [Google Scholar]
  21. Thompson C. E., Damon L. E., Ries C. A., Linker C. A. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992 Oct 15;80(8):1890–1895. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES